MS Patient dies from anti-Tysabri antibodies

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

MS Patient dies from anti-Tysabri antibodies

Postby cheerleader » Mon Feb 11, 2013 11:19 am

Svenningsson and colleagues concluded that her death resulted from "rebound neuroinflammation as a result of the development of natalizumab anti-drug antibodies."

Noteworthy was that the patient had shown unusual reactions to the drug starting with the fourth infusion, including chills and fever, they suggested.

"We recommend that repeated moderate to severe infusion reactions in the beginning of natalizumab treatment should prompt the cessation of treatment and assessment for the development of natalizumab anti-drug antibodies," Svenningsson and colleagues wrote.


http://www.medpagetoday.com/Neurology/M ... osis/37290

The patient died June 2008. The report was submitted for publication four years later.
http://www.neurology.org/content/early/ ... e3.extract
Husband dx RRMS 3/07
dx dual jugular vein stenosis (CCSVI) 4/09
http://ccsviinms.blogspot.com
User avatar
cheerleader
Family Elder
 
Posts: 5017
Joined: Mon Sep 10, 2007 3:00 pm
Location: southern California

Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service